Sign in
4

Changes in Ownership

Perspective Therapeutics, Inc. Filed Acc 0000950170-24-067953

Chief Financial Officer bought 25,006 shares at an average $1.40 ($35,007)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Hunt Jonathan Robert Chief Financial Officer 2024-05-31 Purchase +13,006 $1.40 $18,207 329,716 D: show line 1 in the form
Hunt Jonathan Robert Chief Financial Officer 2024-05-31 Purchase +12,000 $1.40 $16,800 341,716 D: show line 2 in the form
Open-market purchases · 25,006 sh · avg $1.40 · $35,007
Loading xslF345X05/ownership.xml…